Clinical Trial Update: Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled glutathione in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled Glutathione (glutathione)

Snippet

Sponsor: Mukoviszidose Institut gGmbH | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED